Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robin Kamal

Hand Surgery Stanford, CA Medical Doctor

NPI 1144422254 CMS profile 278592

300 Pasteur Dr, Stanford, CA 94305

Open in the dashboard

General payments

$343,096

299 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$92,943 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Robin Kamal of Stanford, CA is reported in the CMS Open Payments database as having received $343,096 across 299 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $92,943 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $65,130 47
2024 General $53,242 33
2023 General $75,438 62
2022 General $49,379 42
2021 General $21,606 34
2020 General $23,089 13
2019 General $55,212 68

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robin Kamal
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Robin Kamal were reported at $65,130. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Robin Kamal Hand Surgery median Middle half National median
2019 $55,212 $383 $106–$1,905 $163
2020 $23,089 $172 $51–$1,268 $114
2021 $21,606 $263 $71–$1,591 $132
2022 $49,379 $336 $87–$1,938 $149
2023 $75,438 $233 $81–$1,114 $160
2024 $53,242 $258 $88–$1,203 $164
2025 $65,130 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Acumed LLC $299,945 243 payments
  2. restor3d, inc. $33,381 5 payments
  3. TriMed, Inc. $5,745 17 payments
  4. AxoGen $2,094 20 payments
  5. ExsoMed Corporation $763 2 payments
  6. Skeletal Dynamics Inc $280 2 payments
  7. Bioventus LLC $237 2 payments
  8. Integra LifeSciences Corporation $148 1 payment
  9. Tenex Health Inc. $148 1 payment
  10. Extremity Medical $147 1 payment
  11. Other $209 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $204,110 80 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $104,054 24 payments
  3. Travel and Lodging $23,116 74 payments
  4. Food and Beverage $11,723 120 payments
  5. Education $94 1 payment
Products named General payments · program years 2019–2025
  1. ACUMED Hand & Wrist $172,063 114 payments
  2. ACUMED Hand & Wrist $94,495 50 payments
  3. Acu-Loc Wrist Plating System $53,587 34 payments
  4. Hand Fracture System $36,891 21 payments
  5. ACUMED Hand & Wrist $24,324 22 payments
  6. OsteoMed Hand & Wrist $23,173 18 payments
  7. Elbow Plating System $22,401 11 payments
  8. OsteoMed Hand & Wrist $22,377 17 payments
  9. INnate Implant $19,787 14 payments
  10. Midshaft Forearm Plating System $19,093 6 payments
  11. Other $195,531 218 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 74 billing codes

Paid by Medicare

$145,776

Of which drugs: $653

Medicare patients

369

Average age 74

Services billed

933

230 women, 139 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 69%
High blood pressure 67%
Ischemic heart disease 27%
Diabetes 26%
Osteoporosis 25%
Cancer 18%
Depression 18%
Chronic kidney disease 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 48 121 $651

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

299 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record